PKM and neoplasm: Fong et al. revealed that tumor cells released vesicles that contained a high number of miRNA-122, which led to the inhibition of glucose uptake in the pre-metastatic niche by non-tumor cells through downregulating the glycolytic enzyme pyruvate kinase (PKM).